Access to anti-retroviral drugs, female in Belgium
Belgium: Access to anti-retroviral drugs, female was 89.0% in 2023. ▲ Rising
Access to anti-retroviral drugs, female in Belgium, 2000–2023
Source: UNAIDS estimates. Measured in %.
Analysis
The most recent figure for access to anti-retroviral drugs, female in Belgium is 89.0%, measured in 2023.
The figure is up 3.5% over ten years.
Over the whole period, access to anti-retroviral drugs, female in Belgium peaked at 90.0% in 2017 and was at its lowest, 41.0%, in 2000.
Belgium ranks 35th of 141 countries on this measure, in the top quarter.
The long-run direction has been consistently rising across the 24 years of available data.
Access to anti-retroviral drugs, female in Belgium, year by year
| Year | % | Change |
|---|---|---|
| 2000 | 41.0% | — |
| 2001 | 46.0% | +12.2% |
| 2002 | 51.0% | +10.9% |
| 2003 | 55.0% | +7.8% |
| 2004 | 60.0% | +9.1% |
| 2005 | 64.0% | +6.7% |
| 2006 | 77.0% | +20.3% |
| 2007 | 77.0% | +0.0% |
| 2008 | 80.0% | +3.9% |
| 2009 | 82.0% | +2.5% |
| 2010 | 85.0% | +3.7% |
| 2011 | 88.0% | +3.5% |
| 2012 | 84.0% | -4.5% |
| 2013 | 86.0% | +2.4% |
| 2014 | 86.0% | +0.0% |
| 2015 | 87.0% | +1.2% |
| 2016 | 88.0% | +1.1% |
| 2017 | 90.0% | +2.3% |
| 2018 | 89.0% | -1.1% |
| 2019 | 87.0% | -2.2% |
| 2020 | 87.0% | +0.0% |
| 2021 | 87.0% | +0.0% |
| 2022 | 89.0% | +2.3% |
| 2023 | 89.0% | +0.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 63.3% | 41.0% | 82.0% | 10 |
| 2010s | 87.0% | 84.0% | 90.0% | 10 |
| 2020s | 88.0% | 87.0% | 89.0% | 4 |
Countries ranked near Belgium
More gender data for Belgium
- Child population (UN estimates and projections) 1,701 (2030)
- Child population (UN estimates and projections) (0-14), annual growth -1.52 % change on previous year (2030)
- Population 10,123 (2030)
- Working-age population (UN estimates and projections) 10,123 (2030)
- Population (UN estimates and projections), annual growth rate 0.3629 % change on previous year (2030)
- Age population, age 00, female, interpolated 49,723 (2025)
- Age population, age 00, male, interpolated 52,153 (2025)
- Age population, age 01, female, interpolated 50,100 (2025)
- Age population, age 01, male, interpolated 52,519 (2025)
- Age population, age 02, female, interpolated 53,460 (2025)
Frequently asked questions
- What is access to anti-retroviral drugs, female in Belgium?
- Access to anti-retroviral drugs, female in Belgium was 89.0% in 2023, according to UNAIDS estimates.
- What is the highest access to anti-retroviral drugs, female recorded in Belgium?
- The highest recorded value was 90.0% in 2017.
- What is the lowest access to anti-retroviral drugs, female recorded in Belgium?
- The lowest recorded value was 41.0% in 2000.
- How does Belgium rank for access to anti-retroviral drugs, female?
- Belgium ranks 35th out of 141 countries with data for 2023.
- Is access to anti-retroviral drugs, female rising or falling in Belgium?
- Over the last ten years it is up 3.5%. The long-run trend across the full record is rising.
- Where does this Belgium data come from?
- The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, female (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 24 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.